Literature DB >> 23875059

Rare presentation of giant cell tumor of bone in the lateral end of the clavicle.

Jeetendra Bajpai1, Sumit Saini, Akansha Bajpai, Ruchit Khera.   

Abstract

PATIENT: Male, 30 FINAL DIAGNOSIS: Giant cell bone tumor Symptoms: Bone swellingpain MEDICATION: - Clinical Procedure: - Specialty: Oncology.
OBJECTIVE: Unusual clinical course.
BACKGROUND: Cooper first reported giant cell tumors (GCT) in the 18(th) century. The clavicle is a rare site for tumors. Metastatic tumors are more common than benign. This is the first case of GCT lateral end of clavicle to be reported in the literature. CASE REPORTS: A 30-year-man was admitted with a 1-year history of progressively increasing swelling and pain over the left lateral end of the clavicle. The plain radiograph and PET scan revealed an expansile radiolucent lesion in the lateral end of the clavicle. Swelling was epiphsio-metaphyseal in location. It demonstrated geographical type of destruction with a narrow zone of transition. There was no periosteal reaction or soft-tissue component. The mitotic activity was found to be 0-1/10 HPF. Diagnosis was confirmed histopathologically. A wide excision of the mass, including 3 cm of healthy tissue of the clavicle, was performed.
CONCLUSIONS: The presence of an expansile lytic lesion of the lateral end of the clavicle should be taken seriously and complete radiological and histopathological investigation should be done and giant cell tumor of the bone should be kept in mind despite its rarity.

Entities:  

Keywords:  clavicle; expansile lytic lesion; giant cell tumour; swelling

Year:  2013        PMID: 23875059      PMCID: PMC3715393          DOI: 10.12659/AJCR.889121

Source DB:  PubMed          Journal:  Am J Case Rep        ISSN: 1941-5923


Background

The clavicle is a rare site for bone tumors [1]; its incidence has been reported to be from 0.45–1.01% of all bone tumors [2]. The peculiarities of the clavicle have clinical significance for the orthopedic oncologist. The overall incidence and relative occurrence of tumors and tumorous lesions of the clavicle resemble those of flat bones and not other long bones [3]. Metastatic tumors are more common than primary tumors in this region. Among primary lesions, malignant tumors are more common than benign [4].

Case Report

A 30-year-old man was admitted with a 1-year history of progressively increasing swelling and pain over the left lateral end of the clavicle. There was no history of trauma to that area. Pain was insidious in onset, dull aching in character, non-radiating and localized to the lateral end of the clavicle without diurnal variations. Pain aggravated on movement of the shoulder. The patient was in good health and had otherwise normal findings. He had swelling of a 5×6 cm bony mass arising from the lateral end of the clavicle, which was lobulated and tender. Signs of “egg shell” crackling were present. The overlying skin was mobile and free. Superficial veins were engorged and local temperature was elevated. The arm abduction was painful. There was no sensory or power loss in the left upper limb. There was no regional lymphadenopathy. We obtained a plain radiograph and a PET scan to characterize the swelling. The plain radiograph (Figures 1 and 2) and PET scan (Figure 3) revealed an expansile radiolucent lesion in the lateral end of the clavicle. The swelling was epiphsiometaphyseal in location. It demonstrated a geographical type of destruction with a narrow zone of transition. There was no periosteal reaction or soft-tissue component. The tumor matrix did not demonstrate any calcification. To confirm diagnosis, fine needle aspiration was done and sent for biopsy, which showed a cellular lesion composed predominantly of sheets of plump, oval, mononuclear cells with mild pleomorphism. The cells had moderate amounts of cytoplasm, and had oval to elongated nucleus with moderate anisokaryosis with irregular nuclear membrane, vesicular nucleus, and 0–1 hpf nucleolus. Admixed amongst these, many multinucleated giant cells were seen distributed in a regular and uniform fashion. No storiform pattern was seen. No new bone formation or necrosis was seen. The mitotic activity was found to be 0–1/10 hpf. Differential diagnosis considered aneurysmal bone, non-ossifying fibroma, eosinophilic granuloma, giant cell tumour, and tuberculous osteomyelitis.
Figure 1

Radiograph showing expansile lytic lesion left clavicle.

Figure 2

Radiograph showing lytic lesion lateral end left clavicle.

Figure 3

PET scan showing involvement of left clavicle.

Diagnosis was made on basis histopathological features. During the operation, the left acromioclavicular joint and its cartilages were found to be free from any involvement. The tumor was not adhering to the underlying structures. A wide excision of the mass, including 3 cm of healthy tissue of the clavicle, was performed. The postoperative period was uneventful. At the follow-up 1 year later, the patient was doing well and did not have any local recurrence or distant metastasis.

Discussion

Cooper first reported giant cell tumors (GCT) in the 18th century; in 1940, Jaffe and Lichtenstein defined GCT more rigorously to distinguish it from other tumors [4]. GCT of bone is an uncommon lesion, representing between 4% and 9.5% of primary bone neoplasms and is thought to originate from un-differentiated cells of the supporting tissues of bone marrow. It is most commonly seen in early adulthood, with a peak incidence in the third decade and with a slight female preponderance; it is usually seen in the skeletally mature patient. The tumor is most commonly located around the knee, with the distal radius being the next most common site. Flat bone involvement is rare [5]. GCT usually occurs after completion of maturation of the skeleton. More than 80% of the patients with GCT are between 20–40 years of age [6]. About 75–90% of GCTs occurs in long tubular bones. More than 50% of GCTs arise in the distal femur and the proximal tibia. Other common sites of involvement include the distal radius and the sacrum. Less common sites include flat bones like ribs, skull, patella, sternum, and clavicle [7]. Giant cell tumor of bone (GCTB) is generally considered a true neoplastic condition with well-defined clinical, radiological, and histopathological features [8]. Radiologically, it is usually lytic and expansile without prominent peripheral sclerosis and periosteal reaction [9]. The histopathological findings are often a mixture of all components, and the differential diagnosis of GCTB, not surprisingly, would include central giant cell granuloma, aneurismal bone cyst (ABC), and osteitis fibrosa cystica (brown tumor) [10]. Fine needle aspiration cytology (FNAC) brings out a large number of giant cells as well as stromal cells. The malignant cells from osseous lesions are easily and readily picked up by FNAC. FNAC thus may play an important role in conservative management of this lesion [11].

Conclusions

We have reported this case to emphasize that GCT of flat bones, especially of the clavicle, is very rare and the diagnosis may be missed, both clinically and radiologically, unless there is a high index of suspicion. The presence of an expansile lytic lesion of the lateral end of the clavicle should be taken seriously and complete radiological and histopathological investigation should be done. Giant cell tumor of bone should be kept in mind, despite its rarity, for any expansile lytic lesion.
  6 in total

Review 1.  From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation.

Authors:  M D Murphey; G C Nomikos; D J Flemming; F H Gannon; H T Temple; M J Kransdorf
Journal:  Radiographics       Date:  2001 Sep-Oct       Impact factor: 5.333

Review 2.  Giant cell tumour of bone: morphological, biological and histogenetical aspects.

Authors:  Mathias Werner
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

3.  Osteoid osteoma of the clavicle.

Authors:  M J Klein; R Lusskin; M H Becker; S C Antopol
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176

4.  Fine-needle aspiration diagnosis of giant cell tumour of bone presenting at unusual sites.

Authors:  Manjula Jain; Hema M Aiyer; Monu Singh; M Narula
Journal:  Diagn Cytopathol       Date:  2002-12       Impact factor: 1.582

5.  Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases.

Authors:  V Minard-Colin; C Kalifa; J-M Guinebretiere; L Brugieres; J Dubousset; J-L Habrand; G Vassal; O Hartmann
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

6.  Giant cell tumor of the scapula associated with secondary aneurysmal bone cyst.

Authors:  Y K Park; K N Ryu; C S Han; Y W Kim; M H Yang
Journal:  J Korean Med Sci       Date:  1991-03       Impact factor: 2.153

  6 in total
  5 in total

Review 1.  Intrathoracic Extension of a Giant Cell Tumour of the Medial End of Clavicle: A Case Report with Review of Literature.

Authors:  Shaswat Mishra; Manish Jain; Sandeep Gavhale; Sagar Bansal; Sanjeev Ghildiyal; Mitali Mokashi
Journal:  Indian J Orthop       Date:  2022-09-02       Impact factor: 1.033

2.  Giant Cell Tumor of Clavicle in an Elderly: Rare Presentation of a Common Tumor with Review of Literature; 1980-2020.

Authors:  Neha Garg; Nadeem Tanveer; Shilpi More; Shivangi Chauhan
Journal:  J Microsc Ultrastruct       Date:  2021-09-08

3.  Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.

Authors:  Fujiang Cao; Tao Liu; Yunqiang Xu; Dongdong Xu; Shiqing Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Giant cell tumor of the clavicle: report of a case in a rare location with consideration of surgical method.

Authors:  Satoshi Nagano; Toru Tsuchimochi; Masahiro Yokouchi; Takao Setoguchi; Hiromi Sasaki; Hirofumi Shimada; Shunsuke Nakamura; Yasuhiro Ishidou; Takuya Yamamoto; Setsuro Komiya
Journal:  BMC Musculoskelet Disord       Date:  2015-06-12       Impact factor: 2.362

5.  Giant cell tumour of clavicle: Occurrence of a common tumour in a rare location.

Authors:  Kavin Khatri; Jagdeep Singh; Anoop Kalia; Anshul Dahuja
Journal:  Int J Surg Case Rep       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.